CATALOGO DEI PRODOTTI DELLA RICERCA

BRONTE, Vincenzo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.839
EU - Europa 10.559
AS - Asia 7.470
SA - Sud America 1.027
AF - Africa 251
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 6
Totale 31.184
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.656
RU - Federazione Russa 3.457
SG - Singapore 3.168
GB - Regno Unito 2.921
CN - Cina 1.938
IT - Italia 1.145
HK - Hong Kong 821
BR - Brasile 811
DE - Germania 635
FR - Francia 545
VN - Vietnam 543
FI - Finlandia 541
IE - Irlanda 449
SE - Svezia 355
KR - Corea 268
BD - Bangladesh 193
UA - Ucraina 152
IN - India 118
NG - Nigeria 105
CA - Canada 100
NL - Olanda 97
TR - Turchia 80
AR - Argentina 78
JP - Giappone 70
ID - Indonesia 64
ZA - Sudafrica 49
ES - Italia 47
MX - Messico 46
AT - Austria 41
PL - Polonia 33
EC - Ecuador 32
IQ - Iraq 32
BE - Belgio 30
CO - Colombia 30
AU - Australia 23
PK - Pakistan 21
MA - Marocco 19
PH - Filippine 18
VE - Venezuela 17
PY - Paraguay 16
SA - Arabia Saudita 16
CZ - Repubblica Ceca 14
TN - Tunisia 14
EG - Egitto 13
PE - Perù 13
KE - Kenya 12
UZ - Uzbekistan 12
CL - Cile 11
MY - Malesia 11
AZ - Azerbaigian 9
BO - Bolivia 9
JM - Giamaica 9
TG - Togo 9
AE - Emirati Arabi Uniti 8
AL - Albania 8
BJ - Benin 8
IL - Israele 8
NZ - Nuova Zelanda 8
OM - Oman 8
UY - Uruguay 8
DZ - Algeria 7
LT - Lituania 7
TW - Taiwan 7
CH - Svizzera 6
CR - Costa Rica 6
DK - Danimarca 6
HU - Ungheria 6
JO - Giordania 6
LB - Libano 6
RO - Romania 6
SI - Slovenia 6
BY - Bielorussia 5
IR - Iran 5
LV - Lettonia 5
NP - Nepal 5
AM - Armenia 4
AO - Angola 4
EE - Estonia 4
MK - Macedonia 4
NI - Nicaragua 4
NO - Norvegia 4
PT - Portogallo 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
ET - Etiopia 3
GR - Grecia 3
GT - Guatemala 3
HN - Honduras 3
HR - Croazia 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
LU - Lussemburgo 3
PA - Panama 3
PS - Palestinian Territory 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
AD - Andorra 2
BH - Bahrain 2
CY - Cipro 2
Totale 31.140
Salva come PNG Salva come JPEG
Città #
Southend 2.673
Singapore 1.651
Ashburn 1.481
Jacksonville 1.245
San Jose 1.121
Moscow 1.051
Chandler 857
Woodbridge 851
Hong Kong 801
Dallas 731
Ann Arbor 635
Verona 614
Houston 445
Dublin 437
The Dalles 409
Council Bluffs 360
Beijing 308
Lawrence 220
Princeton 220
Wilmington 218
Los Angeles 217
New York 200
Munich 171
Ho Chi Minh City 167
Helsinki 143
Nanjing 132
Buffalo 120
Shenyang 119
Jinan 117
Hanoi 104
Abuja 102
Milan 87
Sindelfingen 84
Columbus 81
Tianjin 78
Redmond 75
São Paulo 72
Santa Clara 69
Redondo Beach 67
Hebei 66
Tokyo 60
Nanchang 55
Orem 52
Haikou 51
San Francisco 50
Hangzhou 49
Ningbo 49
Zhengzhou 48
Changsha 44
Jakarta 43
Guangzhou 42
Chicago 41
London 41
Seattle 39
Toronto 39
Amsterdam 36
Jiaxing 35
Brooklyn 34
Taizhou 34
Frankfurt am Main 33
Turku 32
Norwalk 31
Seoul 31
Brussels 29
Chennai 29
Johannesburg 28
Nuremberg 28
Stockholm 28
Dong Ket 27
Montreal 27
Phoenix 27
Boardman 25
Boston 25
Haiphong 25
Taiyuan 25
Atlanta 24
Warsaw 24
Redwood City 22
Rio de Janeiro 22
Da Nang 21
Denver 21
Vienna 21
Brasília 20
Dearborn 20
Dongguan 20
Fuzhou 20
Washington 20
Belo Horizonte 19
Falls Church 19
Madrid 17
Manchester 17
New Delhi 17
Rome 17
Lappeenranta 16
Bologna 15
Grafing 15
Mexico City 15
Paris 15
Quito 14
Ankara 13
Totale 20.355
Salva come PNG Salva come JPEG
Nome #
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients 312
MAP Kinase inhibition reshapes tumour microenvironment of mouse pancreatic cancer by depleting anti-inflammatory macrophages 303
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer 295
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Associated to a B7-1-Expressing Tumor Cell Vaccine Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer. 282
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 267
Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma 260
Unraveling the role of lymph node metastasis in PDAC and dCCA progression 254
CD66b-CD64dimCD115- cells in the human bone marrow represent neutrophil-committed progenitors 254
Myeloid-derived suppressor cell heterogeneity in human cancers 251
Deciphering the state of immune silence in fatal COVID-19 patients 240
Autoimmune B-cell lymphopenia after successful adoptive therapy with telomerase-specific T lymphocytes. 239
IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer 230
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy 224
Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+/Gr-1+ cells. 220
Baricitinib restrains the immune dysregulation in patients with severe COVID-19 218
Feasibility of telomerase-specific adoptive T-cell therapy for B-cell chronic lymphocytic leukemia and solid malignancies 216
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 216
Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo" 215
Antigen specificity of immune suppression by myeloid-derived suppressor cells. 211
Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease 209
Disabled homolog 2 controls pro-metastatic activity of tumor-associated macrophages 209
Altered macrophage differentiation and immune dysfunction in tumor development. 208
Antitumor vaccination: where we stand. 203
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers 201
4PD Functionalized Dendrimers: A Flexible Tool for In Vivo Gene Silencing of Tumor-Educated Myeloid Cells 201
Adoptive immunotherapy of experimental tumors using cytotoxic lymphocytes to carry and deliver toxins 200
Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis 198
A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation). 195
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 195
Active immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen. 192
Activated T cells sustain myeloid-derived suppressor cell-mediated immune suppression 191
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC 190
Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine. 190
Adoptive transfer of lymphokine-activated killer cells loaded with 4'-deoxy-4'-iododoxorubicin: therapeutic effect in mice bearing lung metastases. 188
Antitumour efficacy of lymphokine-activated killer cells loaded with ricin against experimentally induced lung metastases. 188
Human Anti Cancer Cytokine Induced Killer Cells and TheirInteraction With the Host Immune System 186
Anti-tumor activity of cytotoxic T lymphocytes elicited with recombinant and synthetic forms of a model tumor-associated antigen. 184
Role of P2z purinergic receptors in ATP-mediated killing of tumor necrosis factor (TNF)-sensitive and TNF-resistant L929 fibroblasts. 182
A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells 182
A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells. 179
The Emerging Immunological Role of Post-Translational Modifications by Reactive Nitrogen Species in Cancer Microenvironment 176
Anatomically restricted synergistic antiviral activities of innate and adaptive immune cells in the skin. 173
Platelets promote thromboinflammation in SARS-CoV-2 pneumonia 173
The immune modulatory effects of umbilical cord-derived mesenchymal stromal cells in severe COVID-19 pneumonia 173
mTOR and STAT3 Pathway Hyper-Activation is Associated with evated Interleukin-6 Levels in Patients with Shwachman-Diamond Syndrome: Further Evidence of Lymphoid Lineage Impairment 172
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer 171
Activation of p53 in Immature Myeloid Precursor Cells Controls Differentiation into Ly6c+CD103+Monocytic Antigen-Presenting Cells in Tumors 170
MDSCs in cancer: Conceiving new prognostic and therapeutic targets 168
Neutralization of NET-associated human ARG1 enhances cancer immunotherapy 166
The Endless Saga of Monocyte Diversity 165
Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. 165
Adipocytes and Neutrophils Give a Helping Hand to Pancreatic Cancers 163
Characterization of Myeloid-derived Suppressor Cells in a Patient With Lung Adenocarcinoma Undergoing Durvalumab Treatment: A Case Report 163
Detection and functional evaluation of arginase-1 isolated from human PMNs and murine MDSC 162
Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. 159
Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells. 159
Local ablation disrupts immune evasion in pancreatic cancer 158
The cross-talk between myeloid and mesenchymal stem cells of human bone marrow represents a biomarker of aging that regulates immune response and bone reabsorption 158
Anti-L-selectin monoclonal antibody treatment in mice enhances tumor growth by preventing CTL sensitization in peripheral lymph nodes draining the tumor area. 157
Immune tolerance to tumor antigens occurs in a specialized environment of the spleen. 157
Expression of the membrane tetraspanin claudin 18 on cancer cells promotes T lymphocyte infiltration and antitumor immunity in pancreatic cancer 155
Transcription factors in myeloid-derived suppressor cell recruitment and function. 153
Interleukin-10 enhances the therapeutic effectiveness of a recombinant poxvirus-based vaccine in an experimental murine tumor model. 148
New idrosoluble furoxan derivatives having antitumoral activity 147
Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells. 147
Therapeutic antitumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigen. 146
IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients. 145
PDE5 INHIBITOR COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY 144
Nitric oxide furoxan derivative compounds endowed with antitumoral activity 143
Costimulation enhances the active immunotherapy effect of recombinant anticancer vaccines. 142
GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironment 142
Interfacing polymeric scaffolds with primary pancreatic ductal adenocarcinoma cells to develop 3D cancer models. 140
Use of myeloid cell biomarkers for the diagnosis of cancer. 139
Nitric oxide affects immune cells bioenergetics: long-term effects of nitric-oxide derivatives on leukaemic Jurkat cell metabolism 139
IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice. 138
Therapeutic targeting of myeloid-derived suppressor cells. 138
High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells. 138
Role of arginine metabolism in immunity and immunopathology. 137
Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages 136
Peripheral blood immunophenotyping in a large cohort of patients with Shwachman-Diamond syndrome 136
Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ T cell responses by dysregulating antigen-presenting cell maturation. 134
Low dose gemcitabine-loaded lipid nanocapsules target monocytic myeloid-derived suppressor cells and potentiate cancer immunotherapy 134
Arginase 1-Based Immune Modulatory Vaccines Induce Anticancer Immunity and Synergize with Anti-PD-1 Checkpoint Blockade. 133
Preventive vaccination with telomerase controls tumor growth in genetically engineered and carcinogen-induced mouse models of cancer. 133
IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression. 133
Nicotinamide Phosphoribosyltransferase Acts as a Metabolic Gate for Mobilization of Myeloid-Derived Suppressor Cells 133
Leukocyte infiltration in cancer creates an unfavorable environment for antitumor immune responses: a novel target for therapeutic intervention. 132
Derangement of immune responses by myeloid suppressor cells. 132
IL-2 enhances the function of recombinant poxvirus-based vaccines in the treatment of established pulmonary metastases. 132
La risposta immunologica verso antigeni tumorali specifici 132
Resistance of lymphokine-activated T lymphocytes to cell-mediated cytotoxicity. 131
Plasmacytoid Dendritic Cell, Slan+-Monocyte and Natural Killer Cell Counts Function as Blood Cell-Based Biomarkers for Predicting Responses to Immune Checkpoint Inhibitor Monotherapy in Non-Small Cell Lung Cancer Patients 130
Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism. 130
Meccanismi molecolari della lisi mediata dai linfociti citotossici 130
Methods to Measure MDSC Immune Suppressive Activity In Vitro and In Vivo 130
In vivo administration of artificial antigen-presenting cells activates low-avidity T cells for treatment of cancer. 129
Responses of mouse lymphocytes to extracellular ATP. II. Extracellular ATP causes cell type-dependent lysis and DNA fragmentation. 129
Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. 127
Myeloid-derived suppressor cells generated in vitro 127
Interaction of human pancreatic ductal adenocarcinoma cells with polymeric scaffolds to develop tissue-engineered cancer models. 127
Totale 17.557
Salva come PNG Salva come JPEG
Categoria #
all - tutte 106.052
article - articoli 95.081
book - libri 0
conference - conferenze 1.997
curatela - curatele 0
other - altro 1.672
patent - brevetti 1.934
selected - selezionate 0
volume - volumi 5.368
Totale 212.104
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202187 0 0 0 0 0 0 0 0 0 0 0 87
2021/20221.735 106 442 31 52 74 47 70 111 115 89 151 447
2022/20232.728 257 262 303 445 230 632 42 154 294 14 57 38
2023/20241.516 63 98 101 192 209 236 66 140 16 87 239 69
2024/20254.793 275 271 146 710 273 163 330 306 828 281 354 856
2025/202612.678 995 635 782 1.783 2.807 870 1.470 682 1.065 744 329 516
Totale 31.439